Lee Pharmaceuticals, Inc. filed its 1-A on Sep 13, 2022 for the period ending Dec 31, 2021. In this report its auditor, Accell Audit & Compliance, P.A, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0051 USD | +8.51% |
|
+6.25% | -80.23% |
06-26 | RONN Inc. Provides Update on JV Talks With Erisha EV | CI |
05-28 | RONN Inc. Signs Strategic Partnership Engagement Letter with Tobique First Nations Canada | CI |
1st Jan change | Capi. | |
---|---|---|
-80.23% | 4.89M | |
+4.67% | 69.28B | |
-4.43% | 59.73B | |
-12.98% | 59.71B | |
+29.51% | 53.05B | |
+18.21% | 52.03B | |
+5.33% | 51.26B | |
+38.08% | 44.77B | |
+27.28% | 43.69B | |
+66.57% | 38.46B |
- Stock Market
- Equities
- RONN Stock
- News RONN Inc.
- Lee Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt